Font Size:
a
A
A
Keyword [low-dose Decitabine]
Result: 1 - 20 | Page: 1 of 1
1.
Clinical Study Of Low-Dose Decitabine In The Treatment Of Myelodysplastic Syndrome And Acute Myeloid Leukemia
2.
Clinical Study Of Low-Dose Decitabine In The Treatment Of Myelodysplastic Syndrome
3.
Clinical Treatment With Low-Dose Decitabine In Three Patients With Primary Immune Thrombocytopenia
4.
Clinical Analysis On Intermediate To High Risk Myelodysplastic Syndrome Patients Treated By Low Dose Decitabine
5.
A Prospective Clinical Study Of Low-dose Decitabine In The Management Of First-and Second-line Treatments Resis/relap ITP Patients
6.
Clinical Efficacy Of Low Dose Decitabine In The Treatment Of Myelodysplastic Syndrome
7.
Clinical And Mechanistic Study Of Low-dose Decitabine As Part Of Modified Bucy-conditioning In Improving Prognosis Of High-risk AML Patients
8.
Maintenance Therapy With Low-dose Decitabine Combined With Valproic Acid After Allogeneic Stem Cell Transplantation For Patients With Acute Leukemia/Myelodysplastic Syndrome
9.
Low-dose Decitabine For The Treatment Of ITP:A Prospective,One-arm,Single-center Clinical Study
10.
Low Dose Decitabine Assists Mesenchymal Stem Cells To Promote Islets Restoration In Type 2 Diabetic Mice
11.
Meta-analysis Of The Efficacy Of Low-dose Decitabine In The Treatment Of Myelodysplastic Syndrome
12.
Evaluation Of The Efficacy Of Ultra-low Dose Decitabine Combined With Chemotherapy In The Treatment Of High-risk Myelodysplastic Syndrome
13.
The Study Of Low-Dose Decitabine Combined With PD-1 Inhibitor In Enhancing Antitumor Immune Activity
14.
Therapeutic Value Of Low-dose Decitabine In Patients With Intermediate-risk-2/High-risk MDS With ECOG Score>2-?3
15.
Clinical Study Of Yisuifang Combined With EPO/low-dose Decitabine In The Treatment Of Myelodysplastic Syndrome
16.
Low-dose Decitabine Restores Immune Tolerance In Immune Thrombocytopenia Via Modulating Treg Cells And Inhibiting CTLs Toxicity
17.
Low-dose Decitabine Priming With Intermediate-dose Cytarabine Followed By Umbilical Cord Blood Infusion As Consolidation Therapy For Elderly Patients With Acute Myeloid Leukemia:a Phase ? Single-arm Study
18.
Mechanism And Proliferation Promoting Effect Of Low-dose Decitabine On HT29 Colon Cancer Cells
19.
Clinical Efficacy Of Low-dose Decitabine Combined With Cytarabine In The Treatment Of Patients With High-risk MDS
20.
Clinical Study Of Low-dose Decitabine Combined With HAG In The Treatment Of Elderly And Relapsed /Refractory Acute Myeloid Leukemia
<<First
<Prev Next>
Last>>
Jump to